Oral Peptide Delivery Systems: Latest Advances and What They Mean

The Big Challenge With Oral Peptide Delivery

Most peptides cannot survive the journey through the stomach. Acids and enzymes break them down before they reach the bloodstream. This is why most peptide drugs today are given by injection.

But that is changing. Scientists have made major progress in developing oral delivery systems that protect peptides long enough for the body to absorb them. This is one of the most active areas of modern drug research.

Why Oral Delivery Is the Goal

Patients strongly prefer pills and capsules over injections. This is not just about comfort. Oral medications are easier to store, easier to take at home, and tend to lead to better patient adherence.

For peptide therapies that require daily dosing, oral delivery could change how millions of patients manage their conditions. The market potential is enormous, and investment in this area is growing every year.

Semaglutide, the active ingredient in Ozempic, was originally only available as an injection. Novo Nordisk later developed Rybelsus, an oral version, marking a significant advance in oral peptide delivery technology.

Oral bioavailability of most unprotected peptides is less than 2%, meaning over 98% of the dose is destroyed before it ever reaches the bloodstream.

Key Barriers to Oral Peptide Absorption

Understanding the barriers helps explain why the science is so difficult. Peptides face three main obstacles in the gastrointestinal tract.

First, stomach acid can break down peptide bonds. Second, digestive enzymes like proteases attack the peptide structure. Third, the gut wall is not designed to absorb large polar molecules like peptides.

Barrier	Location	Effect on Peptide
Gastric acid (pH 1 to 3)	Stomach	Breaks peptide bonds
Proteases (pepsin, trypsin)	Stomach and small intestine	Degrades peptide structure
Intestinal epithelium	Small intestine	Blocks absorption of large molecules
First-pass metabolism	Liver	Further reduces bioavailability

Nanoparticle Technology for Oral Peptides

One of the most promising advances involves enclosing peptides inside tiny nanoparticles. These particles protect the peptide from acid and enzymes until it reaches the right spot in the gut.

Different materials are used to build these nanoparticles, including lipids, polymers, and chitosan. Each material has different properties that affect how and where the peptide is released.

Expert Quote: "Nanoparticle encapsulation has given us a way to essentially smuggle peptides through the gut. The challenge now is making it scalable and cost-effective for manufacturing." -- Pharmaceutical Scientist, University Research Program

Lipid-based nanoparticles have shown particular promise. They mimic the way the body naturally absorbs fat-soluble nutrients, which helps sneak peptides past the gut wall.

Permeation Enhancers: Opening the Door

Permeation enhancers are compounds added to oral peptide formulations to help peptides cross the gut wall. They temporarily open tight junctions between intestinal cells, creating a path for the peptide to enter the bloodstream.

Sodium caprate is one well-studied permeation enhancer. It is used in the oral semaglutide formulation (Rybelsus) and has shown a strong safety profile in clinical trials.

Other enhancers being studied include bile salt derivatives and fatty acid compounds. Researchers are working to find enhancers that are both effective and safe for long-term use.

Enteric Coating Innovations

Enteric coatings are protective layers placed around a pill that prevent it from dissolving in the stomach. The coating only breaks down when it reaches the higher pH environment of the small intestine.

Modern enteric coatings have become far more sophisticated. New materials allow for precise, targeted release at specific points in the gut, which is critical for peptides that are absorbed best in certain intestinal regions.

Learn about how peptide chemistry research supports drug delivery innovation

Self-Emulsifying Drug Delivery Systems (SEDDS)

SEDDS are liquid or semi-solid formulations that form tiny emulsion droplets when they contact water in the gut. These droplets carry the peptide and help it get absorbed through the intestinal wall.

This technology is already used for some small molecule drugs and is now being adapted for peptides. The key advantage is that it can dramatically improve the apparent solubility of a peptide in the gut.

Researchers have shown SEDDS can increase the oral bioavailability of certain peptides by up to 10 times compared to unformulated peptide. This is a significant improvement, though absolute bioavailability is still lower than injections.

Mucoadhesive Delivery Systems

Mucoadhesive systems stick to the mucous lining of the gut and hold the peptide in close contact with the intestinal wall. This increases the concentration of the peptide at the absorption site and gives it more time to cross.

Polymers like polyacrylic acid (carbomer) and hydroxypropyl methylcellulose are commonly used. These materials bond to mucin proteins in the gut lining and stay in place for hours.

This approach works best in the buccal (mouth) and sublingual (under the tongue) regions, where the tissue is thin and well-supplied with blood vessels.

Enzyme Inhibitor Co-Formulation

Another strategy is to include protease inhibitors directly in the oral peptide formulation. These inhibitors block the enzymes that would normally break down the peptide before it can be absorbed.

Soybean trypsin inhibitor and Bowman-Birk inhibitor are examples of compounds studied for this purpose. They bind to gut enzymes and temporarily reduce their activity.

The challenge with this approach is making sure the inhibitors are safe and do not interfere with normal digestion over long periods of use.

Fact: According to a review published on PubMed, the oral bioavailability of unmodified peptides is typically less than 1 to 2%, which highlights the enormous gap that new delivery technologies are working to close.

Chemical Modification Strategies

Sometimes the peptide itself is modified to make it more stable in the gut or better at crossing membranes. This is different from changing the delivery system and instead changes the molecule directly.

Cyclization, PEGylation, and lipidation are all chemical strategies used to improve oral peptide stability. Cyclized peptides, for example, are more resistant to enzyme degradation because their structure is less accessible to proteases.

Read more about peptide stapling and how it improves molecular stability

Clinical and Commercial Progress

Several oral peptide products have now reached the market or advanced clinical trials. Rybelsus (oral semaglutide) is the most well-known commercial success. It achieved meaningful bioavailability using a combination of enteric coating and a permeation enhancer called SNAC.

Other oral GLP-1 receptor agonists and oral insulin formulations are in late-stage trials. These products would give millions of patients with diabetes a needle-free option for treatment.

Product	Peptide	Company	Stage
Rybelsus	Semaglutide	Novo Nordisk	Approved (FDA)
Orforglipron	Non-peptide GLP-1 agonist	Eli Lilly	Phase 3
OKV-119	Oral GLP-1 peptide	Oramed	Phase 2
MAPI Pharma oral insulin	Insulin	Various	Phase 2

What This Means for the Peptide Industry

The advances in oral peptide delivery are not just exciting for patients. They open up entirely new product categories for peptide manufacturers and developers.

Companies that build expertise in oral peptide formulation now will have a significant competitive advantage as the market matures. The demand for scientists and engineers with this specific skill set is already rising.

FAQ: People Also Ask

Why is oral delivery of peptides so difficult? Peptides are broken down by stomach acid and digestive enzymes before they can be absorbed. The gut wall also blocks large polar molecules from entering the bloodstream.

What is the most successful oral peptide drug so far? Rybelsus (oral semaglutide) is the most well-known success. It uses a permeation enhancer called SNAC to help semaglutide cross the intestinal wall.

What are nanoparticles used for in oral peptide delivery? Nanoparticles protect peptides from acid and enzymes in the gut. They carry the peptide safely to the small intestine where absorption is better.

What is a permeation enhancer? A permeation enhancer is a compound that temporarily opens gaps between intestinal cells, allowing peptides to pass into the bloodstream more easily.

How is oral peptide bioavailability measured? It is measured by comparing the amount of peptide that reaches the blood after oral dosing to the amount that reaches the blood after injection, expressed as a percentage.

Are there oral peptide therapies for diabetes? Yes. Oral semaglutide is already approved. Oral insulin and other GLP-1 receptor agonist peptides are in clinical trials.

What chemical changes can improve oral peptide stability? Cyclization, PEGylation, lipidation, and N-methylation of amino acids can all help peptides survive the harsh environment of the digestive tract.